Newsroom
Are You In The Know? Biomarker Use In Clinical Settings
Dr. Michael Marvin is the Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and a…
Novel Biomarkers in Kidney Transplant: A Focus on Gene Expression Testing
Preliminary results are available from a study examining gene expression testing as a tool for managing immunosuppression in organ transplant patients….
Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care
Dr. John Friedewald serves as Medical Director of Kidney Transplantation at Northwestern Memorial Hospital and is a Professor of Medicine…
TRANSPLANT GENOMICS APPROVED AS MEDI-CAL PARTICIPATING PROVIDER
California’s Medicaid grants TGI participating provider status effective June 5, 2023, providing Medi-Cal patients access to non-invasive rejection testing with…
TRANSPLANT GENOMICS RECEIVES GEISINGER HEALTH PLAN COVERAGE FOR TRUGRAF AND VIRACOR TRAC KIDNEY TESTS
Humana’s kidney transplant patients are covered effective January 30, 2023, for non-invasive rejection testing with the TruGraf® blood gene expression…
Third Circuit Court of Appeals Affirms Judgment in Favor of Eurofins Viracor in Patent Infringement Case
LEE’S SUMMIT, MO [July 19, 2022] – Eurofins Viracor, a leader in infectious disease, immunology, and allergy testing, announced today that…
Transplant Genomics Welcomes Chief Medical Officer Jon Friedman, MD, FAST
Dr. Friedman brings 30 years of success in delivering value for patients, healthcare providers, and payors to help Transplant Genomics…
AJT Article Validates Clinical Utility of Donor-Derived Cell-Free DNA in Detecting Liver Rejection
FRAMINGHAM, MA [8 November 2021] — Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide,…
CJASN Publishes Study Validating the Combination of Biomarkers for Improved Detection of Kidney Rejection
FRAMINGHAM, MA [3 November 2021] — Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide,…
Eurofins Transplant Genomics Enrolls 500th Patient in TRULO Observational Study
Prospective, multi-center clinical study is the first to evaluate the long-term post-transplant clinical outcomes of kidney transplant recipients. FRAMINGHAM, MA…